Results 51 to 60 of about 36,659 (288)

Recent Progress of Novel Electrochemiluminescence Nanoprobes and Their Analytical Applications

open access: yesFrontiers in Chemistry, 2021
High-performance nanomaterials have been seen as a new generation of electrochemiluminescence (ECL) probes or emitters for their finely tunable structure and concomitant remarkable properties, guaranteeing the prospective applications in the analysis and
Shiyu Zhang, Yang Liu
doaj   +1 more source

Synthesis and electrochemiluminescence of bis(2,2 '-bipyridine)(5-amino-1,10-phenanthroline) ruthenium(II)-functionalized gold nanoparticles

open access: yes, 2011
Bis(2,2'-bipyridine)(5-amino-1,10-phenanthroline) ruthenium(II) functionalized gold nanoparticles with electrochemiluminescence activity were successfully synthesized by a simple one-pot method via the reduction of HAuCl(4) with NaBH(4) in the presence ...
Ming Zhou   +5 more
core   +1 more source

Autocatalytic Electrochemiluminescence

open access: yesAngewandte Chemie
Abstract Electrochemiluminescence (ECL) is a powerful analytical technique that generates light through electrochemically induced reactions, enabling ultrasensitive biosensing and imaging of submicrometric objects. Conventional ECL systems, such as those using Ru(bpy) 3 2
Claudia Martinez Asenjo   +9 more
openaire   +3 more sources

Hyperacute Interleukin‐1β Production and Neutrophil Extracellular Trap Formation in the Cerebral Circulation of Stroke Patients with Large Vessel Occlusion

open access: yesAnnals of Neurology, EarlyView.
Acute ischemic stroke due to large vessel occlusion is associated with rapid intravascular immune activation. Analysis of arterial blood sampled distal to the thrombus during mechanical thrombectomy revealed increased extracellular adenosine triphosphate (ATP) and interleukin‐1β (IL‐1β) levels, evidence of inflammasome priming in monocytes, and ...
Justine Münsterberg   +33 more
wiley   +1 more source

Atomically Fe‐anchored MOF‐on‐MOF nanozyme with differential signal amplification for ultrasensitive cathodic electrochemiluminescence immunoassay

open access: yesExploration, 2023
The successful application of electrochemiluminescence (ECL) in immunoassays for clinical diagnosis requires stable electrodes and high‐efficient ECL signal amplification strategies.
Chuanping Li   +2 more
doaj   +1 more source

Facial Preparation of Cyclometalated Iridium (III) Nanowires as Highly Efficient Electrochemiluminescence Luminophores for Biosensing

open access: yesBiosensors, 2023
In this study, highly efficient ECL luminophores composed of iridium complex-based nanowires (Ir–NCDs) were synthesized via covalently linking bis(2-phenylpyridine)-(4-carboxypropyl-2,2′-bipyridyl) iridium(III) hexafluorophosphate with nitrogen-doped ...
Yueyue Huang   +9 more
doaj   +1 more source

Engineered Electrochemiluminescence Biosensors for Monitoring Heavy Metal Ions: Current Status and Prospects

open access: yesBiosensors, 2023
Metal ion contamination has serious impacts on environmental and biological health, so it is crucial to effectively monitor the levels of these metal ions.
Yuanyuan Chen   +3 more
doaj   +1 more source

Proline‐Selective Electrochemiluminescence Detecting a Single Amino Acid Variation Between A1 and A2 β‐Casein Containing Milks

open access: yesAdvanced Science
The proline amino acid and prolyl residues of peptides/proteins confer unique biological and biochemical properties that motivates the development of proline‐selective analysis.
Eunkyoung Kim   +5 more
doaj   +1 more source

Aggregation-Induced Electrochemiluminescence of Platinum(II) Complexes

open access: yes, 2017
We report the electrochemiluminescence properties of square-planar Pt(II) complexes that result from the formation of supramolecular nanostructures. We define this new phenomenon as aggregation-induced electrochemiluminescence (AIECL).
De Cola L.   +3 more
core   +1 more source

Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week‐24 Results of a Phase 3, Randomized, Placebo‐Controlled Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective To evaluate the efficacy and safety of guselkumab, an interleukin‐23p19 subunit inhibitor, in participants with active psoriatic arthritis (PsA) and inadequate response (inadequate efficacy and/or intolerance) to one prior tumor necrosis factor (TNF) inhibitor.
Alexis Ogdie   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy